Trabectedin plus Durvalumab in Patients with Advanced Pretreated Soft Tissue Sarcoma and Ovarian Carcinoma (TRAMUNE): An Open-Label, Multicenter Phase Ib Study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Trabectedin plus Durvalumab in Patients with Advanced Pretreated Soft Tissue Sarcoma and Ovarian Carcinoma (TRAMUNE): An Open-Label, Multicenter Phase Ib Study

Published:2021-12-29 Issue: Volume: Page:
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Toulmonde Maud,Brahmi Mehdi,Giraud Antoine,Chakiba Camille,Bessede Alban,Kind Michèle,Toulza Emilie,Pulido Marina,Albert Sabrina^ORCID,Guégan Jean-Philippe,Cousin Sophie,Mathoulin-Pelissier Simone,Perret Raul^ORCID,Croce Sabrina^ORCID,Blay Jean-Yves^ORCID,Ray-Coquard Isabelle^ORCID,Floquet Anne,Italiano Antoine

Funder

ASTRA ZENECA

PharmaMar

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of Immunotherapy in Sarcomas;International Journal of Molecular Sciences;2024-01-19

2. Trabectedin and Lurbinectedin Modulate the Interplay between Cells in the Tumour Microenvironment—Progresses in Their Use in Combined Cancer Therapy;Molecules;2024-01-09

3. Immune checkpoint inhibitors in sarcomas: a systematic review;Immuno-Oncology and Technology;2023-12

4. “DEPHENCE” system—a novel regimen of therapy that is urgently needed in the high-grade serous ovarian cancer—a focus on anti-cancer stem cell and anti-tumor microenvironment targeted therapies;Frontiers in Oncology;2023-06-28

5. Current Landscape of Immunotherapy for Advanced Sarcoma;Cancers;2023-04-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP